Study protocol of a phase 2, dual-centre, randomised, controlled trial evaluating the effectiveness of probiotic and egg oral immunotherapy at inducing desensitisation or sustained unresponsiveness (remission) in participants with egg allergy compared with placebo (Probiotic Egg Allergen Oral Immunotherapy for Treatment of Egg Allergy: PEAT study)

This study has been approved by the Human Research Ethics Committees at the Royal Children’s Hospital (HREC 2019.082) and the National Healthcare Group Domain Specific Review Board (2019/00029). Results will be published in peer-reviewed journals and disseminated via presentations at international conferences.

Trial registration number
ACTRN12619000480189.

Source: BMJ Open - July 7, 2021 Category: General Medicine Authors: Loke, P., Chebar Lozinsky, A., Orsini, F., Wong, L. S.-Y., Leung, A. S.-Y., Tham, E. H., Lopata, A. L., Shek, L. P.-C., Tang, M. L., PEAT study team, Su, Robinson, Tey, Belousoff, Pitkin, Axelrad, Mitra, Chan, Yi, Ng Tags: Open access, Immunology (including allergy) Source Type: research